Search Results - Gaitani, Stavroula

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Gemtuzumab Ozogamicin for Relapsed and Refractory Acute Myeloid Leukemia and Myeloid Sarcomas

    Gemtuzumab Ozogamicin for Relapsed and Refractory Acute Myeloid Leukemia and Myeloid Sarcomas by Piccaluga, Pier Paolo, Martinelli, Giovanni, Rondoni, Michela, Malagola, Michele, Gaitani, Stavroula, Isidori, Alessandro, Bonini, Alessandro, Gugliotta, Luigi, Luppi, Mario, Morselli, Monica, Sparaventi, Giovanni, Visani, Giuseppe, Baccarani, Michele

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study

    Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms:... by Parissis, John T., Farmakis, Dimitrios, Nikolaou, Maria, Birmpa, Dionysia, Bistola, Vassiliki, Paraskevaidis, Ioannis, Ikonomidis, Ignatios, Gaitani, Stavroula, Venetsanou, Koula, Filippatos, Gerasimos, Kremastinos, Dimitrios Th

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients

    First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients by Piccaluga, Pier Paolo, Martinelli, Giovanni, Rondoni, Michela, Malagola, Michele, Gaitani, Stavroula, Visani, Giuseppe, Baccarani, Michele

    Published in Leukemia research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Efficacy and Toxicity of FLAI-G-CSF and Mylotarg for Induction/Consolidation of AML Patients, Not Treatable with Conventional Chemotherapy

    Efficacy and Toxicity of FLAI-G-CSF and Mylotarg for Induction/Consolidation of AML Patients, Not Treatable with Conventional Chemotherapy by Malagola, Michele, Rondoni, Michela, Russo, Domenico, Piccaluga, Pier Paolo, Paolini, Stefania, Bosi, Costanza, Gaitani, Stavroula, Visani, Giuseppe, Martinelli, Giovanni, Baccarani, Michele

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Anti-Leukemic and Anti-GVHD Effects of Campath-1H in Acute Lymphoblastic Leukemia Relapsed after Stem-Cell Transplantation

    Anti-Leukemic and Anti-GVHD Effects of Campath-1H in Acute Lymphoblastic Leukemia Relapsed after Stem-Cell Transplantation by Piccaluga, Pier Paolo, Martinelli, Giovanni, Malagola, Michele, Rondoni, Michela, Bianchini, Michele, Vigna, Ernesto, Bosi, Costanza, Gaitani, Stavroula, Visani, Giuseppe, Baccarani, Michele

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib

    Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib by Martinelli, Giovanni, Cilloni, Daniela, Ottaviani, Emanuela, Malagola, Michele, Messa, Francesca, Rondoni, Michela, Bosi, Costanza, Gottardi, Enrico, Rosti, Gianantonio, Ricci, Paolo, Gaitani, Stavroula, Pane, Fabrizio, Testoni, Nicoletta, Mecucci, Cristina, Soverini, Simona, Piccaluga, Pier Paolo, Amabile, Marilina, Tiribelli, Mario, Zaccaria, Alfonso, Grafone, Tiziana, De Vivo, Antonello, Pileri, Stefano, Fattori, Pierpaolo, Bocchia, Monica, Serra, Anna, Maurillo, Luca, Fanin, Renato, Cross, Nicholas C.P., Merante, Serena, Cazzola, Mario, Alimena, Giuliana, Frassoni, Francesco, Galieni, Piero, Russo, Domenico, Gobbi, Marco, Gugliotta, Luigi, Lauria, Francesco, Mazza, Patrizio, Ferrara, Felicetto, Gherlinzoni, Filippo, Leoni, Pietro, Musto, Pellegrino, Baccarani, Michele, Saglio, Giuseppe

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia

    Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia by Piccaluga, Pier Paolo, Malagola, Michele, Rondoni, Michela, Amabile, Marilina, Paolini, Stefania, Soverini, Simona, Gaitani, Stavroula, Visani, Giuseppe, Baccarani, Michele, Martinelli, Giovanni

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia

    Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia by Piccaluga, Pier Paolo, Luatti, Simona, Ascani, Stefano, Bianchini, Michele, Malagola, Michele, Rondoni, Michela, Gaitani, Stavroula, Testoni, Nicoletta, Pileri, Stefano A, Baccarani, Michele, Martinelli, Giovanni, Visani, Giuseppe

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  9. 9
    Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia

    Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia by Piccaluga, Pier Paolo, Malagola, Michele, Rondoni, Michela, Amabile, Marilina, Paolini, Stefania, Soverini, Simona, Gaitani, Stavroula, Visani, Giuseppe, Baccarani, Michele, Martinelli, Giovanni

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: